Ladenburg Thalmann Financial Services’s Capricor Therapeutics CAPR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	270	–	–	﹤0.01%	5330
2019 Q3	$1K	Hold	270	–	–	﹤0.01%	5081
2019 Q2	$1K	Hold	270	–	–	﹤0.01%	5077
2019 Q1	$1K	Hold	270	–	–	﹤0.01%	5044
2018 Q4	$1K	Sell	270 -750	-74%	-$5.96K	﹤0.01%	5008
2018 Q3	$11K	Buy	1,020 +750	+278%	+$8.93K	﹤0.01%	4221
2018 Q2	$4K	Hold	270	–	–	﹤0.01%	4651
2018 Q1	$4K	Buy	+270	New	+$4.68K	﹤0.01%	4651

Other funds holding CAPR

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CBA

Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CAPR Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Capricor Therapeutics (CAPR) position steady in Q4 2019 at 270 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5330.

Ladenburg Thalmann Financial Services first reported a position in CAPR in Q1 2018 and has held it in 8 quarters since. The position peaked at $11K in Q3 2018. 17 funds tracked by Wall St. Rank hold CAPR as of Q4 2019.

Ladenburg Thalmann Financial Services held 270 shares of Capricor Therapeutics worth $0 as of Q4 2019.
Ladenburg Thalmann Financial Services left its Capricor Therapeutics share count unchanged in Q4 2019.
Capricor Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5330 holding.
Ladenburg Thalmann Financial Services first reported a position in Capricor Therapeutics in Q1 2018 and has held it in 8 quarters since.
Ladenburg Thalmann Financial Services's Capricor Therapeutics position peaked at $11K in Q3 2018.
17 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.